# Role of Colchicine as Anti-Inflammatory Therapy in HFpEF

> **NCT06837623** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Cairo University** · enrollment: 75 (estimated)

## Conditions studied

- HFpEF - Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Colchicine Tablets

## Key facts

- **NCT ID:** NCT06837623
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-02-22
- **Final completion:** 2025-03-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06837623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06837623, "Role of Colchicine as Anti-Inflammatory Therapy in HFpEF". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06837623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*